Abstract:A series of new acylthiourea derivatives 3 containing carbazole moity have been synthesized by the techniques of ultrasonic irradiation and solid-liquid phase transfer catalysis. Their structures were characterized by IR, H-1 NMR, C-13 NMR spectra and elemental analysis. This synthetic method has the advantages of short reaction time, simple operation and high yield. All synthesized target compounds were screened for their inhibitory activity against cell division cycle 25B phosphatase (Cdc25B) and protein tyrosine phosphatase 1B (PTP1B). The results show that all the compounds 3 display significant inhibitory activities against Cdc25B, and partial target compounds 3 also show significant inhibitory activities against PTP1B. Among them, 1-(4-nitrobenzoy1)-3-(9-ethyl-carbazole-3-yl)thiourea (3n) exhibits highest inhibitory activity against Cdc25B [IC50 = (0.49 +/- 0.12) mu g/mL] and 1-(2-nitrobenzoy1)-3-(9-ethyl-carbazole-3-yl)thiourea (31) displays highest inhibitory activity against PTP1B [IC50 =(3.59 +/- 1.15) mu g/mL]. It is noteworthy that compound 3n shows higher inhibitory activity against Cdc25B and PTP1B. The preliminary research results of molecular docking revealed the structural-activity of the inhibitors. The active compounds can be considered as potential Cdc25B and PTP1B inhibitors, and have great application prospects in the treatment of cancers and diabetes.

Synthesis and biological evaluation of novel thiadiazole amides as potent Cdc25B and PTP1B inhibitors.

Synthesis and Biological Evaluation of N-acylhydrazone Derivatives Containing Benzimidazole Moiety as Cdc25B and PTP1B Inhibitors

Synthesis and Cell Division Cycle 25B Phosphatase/Protein Tyrosine Phosphatase 1B Inhibitory Activity Evaluation of Novel Acylthiourea Derivatives

Synthesis and Cdc25B Inhibition Activity of Novel Imidazo[2,1-b][1,3,4]thiadiazole Derivatives

Synthesis and PTP1B/TCPTP Inhibitory Activity Evaluation of Novel 2,5-Disubstituted-1,3,4-thiadiazolamide Derivatives Containing Carbazole/Benzimidazole Moity

Synthesis and Cell Division Cycle 25b Phosphatase and Protein Tyrosine Phosphatase 1b Inhibitory Activity Evaluation of Novel 3,6-Disubstituted Triazolothiadiazole Derivatives

Synthesis And Cdc25b/Ptp1b Inhibitory Activity Evaluation Of Novel Carbazole-Based Mono-/Bis-Thiocarbohydrazone Derivatives

Novel thiophene derivatives as PTP1B inhibitors with selectivity and cellular activity.

Identification of 1,3,4-Thiadiazolyl-Containing Thiazolidine-2,4-dione Derivatives as Novel PTP1B Inhibitors with Antidiabetic Activity

Synthesis and Biological Evaluation of (±)-3-(2-(2-fluorobenzyloxy) Naphthalen-6-yl)-2-aminopropanoic Acid Derivatives As Novel PTP1B Inhibitors.

Synthesis and Biological Evaluation of Novel Bis-Aromatic Amides As Novel PTP1B Inhibitors

Synthesis and Cdc25B/PTP1B Inhibitory Activity Evaluation of Novel Acylhydrazone Derivatives Containing Carbazole Moity

Synthesis of Miltirone Analogues As Inhibitors of Cdc25 Phosphatases

Synthesis, Characterization and Biological Activities of 3,5,6-Trisubstituted-1,2,4-triazine Derivatives

Synthesis of Tanshinone IIA Analogues and Their Inhibitory Activities Against Cdc25 Phosphatases

Discovery of Core-Structurally Novel PTP1B Inhibitors with Specific Selectivity Containing Oxindole-Fused Spirotetrahydrofurochroman by One-Pot Reaction.

Design, synthesis, biological evaluation and molecular dynamics simulation studies of imidazolidine-2,4-dione derivatives as novel PTP1B inhibitors

Synthesis and Antiproliferative Activity of Thiadiazole Peptidomimetic Derivatives

Design, synthesis, in silico and in vitro evaluation of thiophene derivatives: A potent tyrosine phosphatase 1B inhibitor and anticancer activity

Synthesis and Biological Evaluation of Oleanolic Acid Derivatives As Novel Inhibitors of Protein Tyrosine Phosphatase 1B

Synthesis and Biological Activities of Novel 2,5-Disubstituted-1,3,4-thiadiazole Derivatives